Enovis (ENOV) EPS (Basic) Growth (1y) (2011 - 2026)
Enovis (ENOV) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 51.01% |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 84.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 84.69% |
| Dec 31, 2025 | 28.50% |
| Oct 3, 2025 | -1,622.41% |
| Jul 4, 2025 | -88.24% |
| Apr 4, 2025 | 25.76% |
| Dec 31, 2024 | -2,986.36% |
| Sep 27, 2024 | -61.11% |
| Jun 28, 2024 | -25.93% |
| Mar 29, 2024 | -206.98% |
| Dec 31, 2023 | 143.56% |
| Sep 29, 2023 | 70.49% |
| Jun 30, 2023 | -112.11% |
| Mar 31, 2023 | 39.44% |
| Dec 31, 2022 | -2,425.00% |
| Sep 30, 2022 | -369.23% |
| Jul 1, 2022 | 298.21% |
| Apr 1, 2022 | -273.17% |
| Dec 31, 2021 | -116.67% |
| Oct 1, 2021 | -316.67% |
| Jul 2, 2021 | 1,033.33% |